Cat. No.: X23-10-ZQ425
JAK inhibitor Tyk2-IN-3, Purity ≥98%
Synonym: 1779493-12-7; (R)-N-(1-(3-(8-Methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)-2-(methylsulfonyl)benzamide; Tyk2-IN-3; N-[(1R)-1-[3-[12-Methyl-8-(methylamino)-5-thia-3,7,10,12-tetrazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),3,7,10-pentaen-4-yl]phenyl]ethyl]-2-methylsulfonylbenzamide; JAK inhibitor
- CAS Number: 1779493-12-7
- Compound CID: 101043725
Product Size
1 mg; 5 mg; 10 mg; 25 mg
Properties
Description
Tyk2-IN-3 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets Tyk2.
Molecular Formula
C25H24N6O3S2
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Tyk2-IN-3 can be utilized to study the inhibition of Tyk2 kinase in autoimmune disease models.
Related Products
- JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
- JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
- JAK inhibitor Abrocitinib, Purity ≥98%
- JAK inhibitor AZ-3, Purity ≥98%
- JAK inhibitor AZ-960, Purity ≥98%
- JAK inhibitor AZD1480, Purity ≥98%
